Who was studied, and how
Three numbers in the abstract
Where each one falls
Where it lands on the map
200people in the The Effects of Thiazolidinedione on the Diabetic Retinopathy and Nephropathy trial, from 2010
30of them with kidney disease, in this paper
The trial randomly assignedassigned by chance
pioglitazone
acarbose
Reported lower kidney function, no range given−7.00
randomisedthe abstract, start to end
… changes in UACR were -18 ± 104 and 12 ± 85 (p = 0.25, between groups) for …
The mean changes in eGFR were 0 ± 14 and -7 ± 16 mL/min/1.73 m2 (p = 0.09, …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
Kidney outcomes
85
EGFRpioglitazone vs acarbose
−7
Kidney outcomes
16
ThiazolidinedionesOther glucose-loweringKidney outcomes
1 / 4